Neuroglycopenia: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(6 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{SI}}
{{Neuroglycopenia}}
'''For patient information, click [[{{PAGENAME}} (patient information)|here]].'''
 
{{CMG}}
{{CMG}}


==Overview==
==[[Neuroglycopenia overview|Overview]]==
'''Neuroglycopenia''' is a medical term that refers to a shortage of [[glucose]] (glycopenia) in the [[brain]], usually due to [[hypoglycemia]]. Glycopenia affects the function of neurons, and alters brain function and behavior. Prolonged neuroglycopenia can result in permanent damage to the brain.


==Pathophysiology==
==[[Neuroglycopenia classification|Classification]]==
===Compensatory responses to neuroglycopenia===
Most neurons have the ability to use other fuels besides glucose (e.g., [[lactic acid]], [[ketone]]s). Our knowledge of the "switchover" process is incomplete. The most severe neuroglycopenic symptoms occur with hypoglycemia caused by [[hyperinsulinemic hypoglycemia|excess insulin]] because [[insulin]] reduces the availability of other fuels by suppressing [[ketogenesis]] and [[gluconeogenesis]].


A few types of specialized [[neuron]]s, especially in the [[hypothalamus]], act as glucose sensors, responding to changing levels of glucose by increasing or decreasing their firing rates. They can elicit a variety of [[hormone|hormonal]], [[autonomic nervous system|autonomic]], and behavioral responses to neuroglycopenia. The hormonal and autonomic responses include release of [[counterregulatory hormone]]s. There is some evidence that the autonomic nervous system can alter [[liver]] glucose [[metabolism]] independently of the counterregulatory hormones. 
==[[Neuroglycopenia pathophysiology|Pathophysiology]]==


Adjustment of efficiency of transfer of glucose from blood across the [[blood-brain barrier]] into the [[central nervous system]] represents a third form of compensation which occurs more gradually. Levels of glucose within the central nervous system are normally lower than the blood, regulated by an incompletely understood transfer process. Chronic hypoglycemia or [[hyperglycemia]] seems to result in an increase or decrease in efficiency of transfer to maintain CNS levels of glucose within an optimal range.
==[[Neuroglycopenia causes|Causes]]==


In both young and old patients, the brain may habituate to low glucose levels, with a reduction of noticeable symptoms, sometimes despite neuroglycopenic impairment. In insulin-dependent [[diabetes|diabetic]] patients this phenomenon is termed ''hypoglycemia unawareness'' and is a significant clinical problem when improved [[Diabetes management#Glycemic control|glycemic control]] is attempted. Another aspect of this phenomenon occurs in [[glycogen storage disease|type I glycogenosis]], when chronic hypoglycemia before diagnosis may be better tolerated than acute hypoglycemia after treatment is underway.
==[[Neuroglycopenia differential diagnosis|Differentiating Neuroglycopenia from other Diseases]]==


===Neuroglycopenia without hypoglycemia===
==[[Neuroglycopenia epidemiology and demographics|Epidemiology and Demographics]]==
A rare metabolic disease of the blood-brain glucose transport system has been described in which severe neuroglycopenic effects occurred despite normal blood glucose levels. Low levels of glucose were discovered in the [[cerebrospinal fluid]] (CSF), a condition referred to as ''hypoglycorrhacia''.


Perhaps a much more common example of the same phenomenon occurs in the people with poorly [[Diabetes management#Glycemic control|controlled]] [[type 1 diabetes]] who develop symptoms of hypoglycemia at levels of blood glucose which are normal for most people.
==[[Neuroglycopenia risk factors|Risk Factors]]==


==Symptoms==
==[[Neuroglycopenia natural history, complications and prognosis|Natural History, Complications and Prognosis]]==


* Abnormal mentation, impaired judgement
==Diagnosis==
* Nonspecific [[dysphoria]], [[anxiety]], moodiness, [[depression]], crying, fear of dying
[[Neuroglycopenia history and symptoms|History and Symptoms]] | [[Neuroglycopenia physical examination|Physical Examination]] | [[Neuroglycopenia laboratory findings|Laboratory Findings]] | [[Neuroglycopenia electrocardiogram|Electrocardiogram]] | [[Neuroglycopenia CT|CT]] | [[Neuroglycopenia MRI|MRI]] | [[Neuroglycopenia other imaging findings|Other Imaging Findings]] | [[Neuroglycopenia other diagnostic studies|Other Diagnostic Studies]]
* Negativism, irritability, belligerence, combativeness, rage
* Personality change, emotional lability
* [[Fatigue]], [[weakness]], [[apathy]], [[lethargy]], daydreaming, sleep
* [[Confusion]], [[amnesia]], [[dizziness]], [[delirium]]
* Staring, "glassy" look, blurred vision, [[double vision]]
* Automatic behavior
* Difficulty speaking, slurred speech
* [[Ataxia]], incoordination, sometimes mistaken for "drunkenness"
* Focal or general motor deficit, paralysis, hemiparesis
* [[Paresthesias]], [[headache]]  
* [[Stupor]], [[coma]], abnormal breathing
* Generalized or [[focal seizures]]  


Not all of the above manifestations occur in every case of hypoglycemia. There is no consistent order to the appearance of the symptoms. Specific manifestations vary by age and by the severity of the hypoglycemia. In older children and adults, moderately severe hypoglycemia can resemble mania, mental illness, drug intoxication, or drunkenness. In the elderly, hypoglycemia can produce focal stroke-like effects or a hard-to-define malaise. The symptoms of a single person do tend to be similar from episode to episode.
==Treatment==
[[Neuroglycopenia medical therapy|Medical Therapy]] | [[Neuroglycopenia primary prevention|Primary Prevention]] | [[Neuroglycopenia secondary prevention|Secondary Prevention]] | [[Neuroglycopenia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Neuroglycopenia future or investigational therapies|Future or Investigational Therapies]]


In the large majority of cases, hypoglycemia severe enough to cause seizures or unconsciousness can be reversed without obvious harm to the brain. Cases of death or permanent neurologic damage occurring with a single episode have usually involved prolonged, untreated unconsciousness, interference with breathing, severe concurrent disease, or some other type of vulnerability. Nevertheless, brain damage or death has occasionally resulted from severe hypoglycemia (e.g., [[Sunny von Bülow]]).
==Case Studies==
[[Neuroglycopenia case study one|Case #1]]


==Physical Examination==
==Related Chapters==
===Neurologic===
*[[Hypoglycemia]]
* Generalized or [[focal seizures]]  
* Focal or general motor deficit, paralysis, hemiparesis
* Weakness
* Ataxia, incoordination


==References==
{{Reflist|2}}
[[Category:Neurology]]
[[Category:Neurology]]
[[Category:Medical emergencies]]
[[Category:Medical emergencies]]

Latest revision as of 16:51, 4 March 2013

Neuroglycopenia Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Neuroglycopenia from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neuroglycopenia On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neuroglycopenia

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neuroglycopenia

CDC on Neuroglycopenia

Neuroglycopenia in the news

Blogs on Neuroglycopenia

Directions to Hospitals Treating Neuroglycopenia

Risk calculators and risk factors for Neuroglycopenia

For patient information, click here.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Classification

Pathophysiology

Causes

Differentiating Neuroglycopenia from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | CT | MRI | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Related Chapters

Template:WH Template:WikiDoc Sources